Assessment and prognosis of peripheral artery measures of vascular function

Progress in Cardiovascular Diseases

Volumn 57, Issue 5, 2015, Pages 497-509

  Anderson, Todd J ^a   Phillips, Shane A ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Atherosclerosis; Doppler; Endothelium; Laser; Plethysmography; Ultrasound; Vascular function

Indexed keywords

ARTERY; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL BIOPSY; BLOOD VESSEL FUNCTION; CARDIOVASCULAR SYSTEM EXAMINATION; CORONARY ARTERY DISEASE; ENDOTHELIAL DYSFUNCTION; EVIDENCE BASED PRACTICE; FLOW MEDIATED DILATION; FLOW MEDIATED VASOCONSTRICTION; HUMAN; HYPEREMIC VELOCITY; LASER DOPPLER FLOWMETRY; MICROVASCULATURE; NONHUMAN; PRACTICE GUIDELINE; PROGNOSIS; PULSE ARTERIAL TONOMETRY; PULSE WAVE; REPERFUSION INJURY; THORAX PAIN; VASCULAR EQUIPMENT; VASCULAR RESISTANCE; ANIMAL; BLOOD FLOW; HEMODYNAMICS; HYPEREMIA; MANOMETRY; MICROCIRCULATION; PATHOLOGY; PATHOPHYSIOLOGY; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE; VASCULAR ENDOTHELIUM;

ANIMALS; ARTERIES; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; ENDOTHELIUM, VASCULAR; HEMODYNAMICS; HUMANS; HYPEREMIA; LASER-DOPPLER FLOWMETRY; MANOMETRY; MICROCIRCULATION; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULSE WAVE ANALYSIS; REGIONAL BLOOD FLOW;

EID: 84924700260     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2014.11.005     Document Type: Article

References (89)

1. Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980, 288:373-376.
2. Flammer A.J., Anderson T., Celermajer D.S., et al. The assessment of endothelial function: From research into clinical practice. Circulation 2012, 126:753-767.
3. Triggle C.R., Samuel S.M., Ravishankar S., Marei I., Arunachalam G., Ding H. The endothelium: Influencing vascular smooth muscle in many ways. Can J Physiol Pharmacol 2012, 90:713-738.
4. Anderson T.J., Uehata A., Gerhard M.D., et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995, 26:1235-1241.
5. Celermajer D.S., Sorensen K.E., Gooch V.M., et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992, 340:1111-1115.
6. Anderson T.J., Meredith I.T., Yeung A.C., Frei B., Selwyn A.P., Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995, 332:488-493.
7. Lekakis J., Abraham P., Balbarini A., et al. Methods for evaluating endothelial function: A position statement from the european society of cardiology working group on peripheral circulation. Eur J Cardiovasc Prev Rehabil 2011, 18:775-789.
8. Ludmer P.L., Selwyn A.P., Shook T.L., et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986, 315:1046-1051.
9. Zeiher A.M., Drexler H., Wollschlaeger H., Saurbier B., Just H. Coronary vasomotion in response to sympathetic stimulation in humans: Importance of the functional integrity of the endothelium. J Am Coll Cardiol 1989, 14:1181-1190.
10. Anderson E.A., Mark A.L. Flow-mediated and reflex changes in large peripheral artery tone in humans. Circulation 1989, 79:93-100.
11. Joannides R., Haefeli W.E., Linder L., et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995, 91:1314-1319.
12. Corretti M.C., Anderson T.J., Benjamin E.J., et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the international brachial artery reactivity task force. J Am Coll Cardiol 2002, 39:257-265.
13. Thijssen D.H., Black M.A., Pyke K.E., et al. Assessment of flow-mediated dilation in humans: A methodological and physiological guideline. Am J Physiol Heart Circ Physiol 2011, 300:H2-H12.
14. Pyke K.E., Hartnett J.A., Tschakovsky M.E. Are the dynamic response characteristics of brachial artery flow-mediated dilation sensitive to the magnitude of increase in shear stimulus?. J Appl Physiol 2008, 105:282-292.
15. Donald A.E., Halcox J.P., Charakida M., et al. Methodological approaches to optimize reproducibility and power in clinical studies of flow-mediated dilation. J Am Coll Cardiol 2008, 51:1959-1964.
16. Verma S., Wang C.H., Lonn E., et al. Cross-sectional evaluation of brachial artery flow-mediated vasodilation and C-reactive protein in healthy individuals. Eur Heart J 2004, 25:1754-1760.
17. Luscher T.F., Taddei S., Kaski J.C., et al. Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: The dal-VESSEL randomized clinical trial. Eur Heart J 2012, 33:857-865.
18. Yeboah J., Crouse J.R., Hsu F.C., Burke G.L., Herrington D.M. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: The cardiovascular health study. Circulation 2007, 115:2390-2397.
19. Yeboah J., Folsom A.R., Burke G.L., et al. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: The multi-ethnic study of atherosclerosis. Circulation 2009, 120:502-509.
20. Lind L., Berglund L., Larsson A., Sundstrom J. Endothelial function in resistance and conduit arteries and 5-year risk of cardiovascular disease. Circulation 2011, 123:1545-1551.
21. Anderson T.J., Charbonneau F., Title L.M., et al. Microvascular function predicts cardiovascular events in primary prevention: Long-term results from the firefighters and their endothelium (FATE) study. Circulation 2011, 123:163-169.
22. Gori T., Dragoni S., Lisi M., et al. Conduit artery constriction mediated by low flow a novel noninvasive method for the assessment of vascular function. J Am Coll Cardiol 2008, 51:1953-1958.
23. Gori T., Parker J.D., Munzel T. Flow-mediated constriction: Further insight into a new measure of vascular function. Eur Heart J 2011, 32:784-787.
24. Panza J.A., Quyyumi A.A., Brush J.E., Epstein S.E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990, 323:22-27.
25. Creager M.A., Cooke J.P., Mendelsohn M.E., et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990, 86:228-234.
26. Hokanson D.E., Sumner D.S., Strandness D.E. An electrically calibrated plethysmograph for direct measurement of limb blood flow. IEEE Trans Biomed Eng 1975, 22:25-29.
27. Johnstone M.T., Creager S.J., Scales K.M., Cusco J.A., Lee B.K., Creager M.A. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 1993, 88:2510-2516.
28. Meredith I.T., Currie K.E., Anderson T.J., Roddy M.A., Ganz P., Creager M.A. Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide. Am J Physiol 1996, 270:H1435-H1440.
29. Heitzer T., Schlinzig T., Krohn K., Meinertz T., Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001, 104:2673-2678.
30. Mitchell G.F., Parise H., Vita J.A., et al. Local shear stress and brachial artery flow-mediated dilation: The framingham heart study. Hypertension 2004, 44:134-139.
31. Huang A.L., Silver A.E., Shvenke E., et al. Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery. Arterioscler Thromb Vasc Biol 2007, 27:2113-2119.
32. Kuvin J.T., Patel A.R., Sliney K.A., et al. Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J 2003, 146:168-174.
33. Nohria A., Gerhard-Herman M., Creager M.A., Hurley S., Mitra D., Ganz P. Role of nitric oxide in the regulation of digital pulse volume amplitude in humans. J Appl Physiol 2006, 101:545-548.
34. Martin B.J., Gurtu V., Chan S., Anderson T.J. The relationship between peripheral arterial tonometry and classic measures of endothelial function. Vasc Med 2013, 18:13-18.
35. Hamburg N.M., Palmisano J., Larson M.G., et al. Relation of brachial and digital measures of vascular function in the community: The framingham heart study. Hypertension 2011, 57:390-396.
36. Hamburg N.M., Keyes M.J., Larson M.G., et al. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the framingham heart study. Circulation 2008, 117:2467-2474.
37. Schnabel R.B., Schulz A., Wild P.S., et al. Noninvasive vascular function measurement in the community: Cross-sectional relations and comparison of methods. Circ Cardiovasc Imaging 2011, 4:371-380.
38. Rubinshtein R., Kuvin J.T., Soffler M., et al. Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J 2010, 31:1142-1148.
39. Matsuzawa Y., Sugiyama S., Sumida H., et al. Peripheral endothelial function and cardiovascular events in high-risk patients. J Am Heart Assoc 2013, 2:e000426. 10.1161/JAHA.113.000426.
40. Xu Y., Arora R.C., Hiebert B.M., et al. Non-invasive endothelial function testing and the risk of adverse outcomes: A systematic review and meta-analysis. Eur Heart J Cardiovasc Imaging 2014, 15:736-746.
41. Roustit M., Cracowski J.L. Non-invasive assessment of skin microvascular function in humans: An insight into methods. Microcirculation 2012, 19:47-64.
42. Mahe G., Durand S., Humeau-Heurtier A., Leftheriotis G., Abraham P. Impact of experimental conditions on noncontact laser recordings in microvascular studies. Microcirculation 2012, 19:669-675.
43. Mahe G., Humeau-Heurtier A., Durand S., Leftheriotis G., Abraham P. Assessment of skin microvascular function and dysfunction with laser speckle contrast imaging. Circ Cardiovasc Imaging 2012, 5:155-163.
44. Binggeli C., Spieker L.E., Corti R., et al. Statins enhance postischemic hyperemia in the skin circulation of hypercholesterolemic patients: A monitoring test of endothelial dysfunction for clinical practice?. J Am Coll Cardiol 2003, 42:71-77.
45. Roustit M., Blaise S., Millet C., Cracowski J.L. Reproducibility and methodological issues of skin post-occlusive and thermal hyperemia assessed by single-point laser Doppler flowmetry. Microvasc Res 2010, 79:102-108.
46. Jonk A.M., Houben A.J., de Jongh R.T., Serne E.H., Schaper N.C., Stehouwer C.D. Microvascular dysfunction in obesity: A potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. Physiology (Bethesda) 2007, 22:252-260.
47. Phillips S.A., Hatoum O.A., Gutterman D.D. The mechanism of flow-induced dilation in human adipose arterioles involves hydrogen peroxide during CAD. Am J Physiol Heart Circ Physiol 2007, 292:H93-H100.
48. Larsen B.T., Bubolz A.H., Mendoza S.A., Pritchard K.A., Gutterman D.D. Bradykinin-induced dilation of human coronary arterioles requires NADPH oxidase-derived reactive oxygen species. Arterioscler Thromb Vasc Biol 2009, 29:739-745.
49. Hatoum O.A., Binion D.G., Miura H., Telford G., Otterson M.F., Gutterman D.D. Role of hydrogen peroxide in ACh-induced dilation of human submucosal intestinal microvessels. Am J Physiol Heart Circ Physiol 2005, 288:H48-H54.
50. Mulvany M.J. Small artery remodelling in hypertension. Basic Clin Pharmacol Toxicol 2012, 110:49-55.
51. Goode G.K., Heagerty A.M. In vitro responses of human peripheral small arteries in hypercholesterolemia and effects of therapy. Circulation 1995, 91:2898-2903.
52. Rizzoni D., Porteri E., Castellano M., et al. Endothelial dysfunction in hypertension is independent from the etiology and from vascular structure. Hypertension 1998, 31:335-341.
53. Dharmashankar K., Welsh A., Wang J., et al. Nitric oxide synthase-dependent vasodilation of human subcutaneous arterioles correlates with noninvasive measurements of endothelial function. Am J Hypertens 2012, 25:528-534.
54. Rizzoni D., Porteri E., Boari G.E., et al. Prognostic significance of small-artery structure in hypertension. Circulation 2003, 108:2230-2235.
55. Tyberg J.V., Bouwmeester J.C., Parker K.H., Shrive N.G., Wang J.J. The case for the reservoir-wave approach. Int J Cardiol 2014, 172:299-306.
56. Kim D.H., Braam B. Assessment of arterial stiffness using applanation tonometry. Can J Physiol Pharmacol 2013, 91:999-1008.
57. O'Rourke M. Arterial stiffness, systolic blood pressure, and logical treatment of arterial hypertension. Hypertension 1990, 15:339-347.
58. Wilkinson I.B., Hall I.R., MacCallum H., et al. Pulse-wave analysis: Clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol 2002, 22:147-152.
59. Mitchell G.F., Parise H., Benjamin E.J., et al. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: The framingham heart study. Hypertension 2004, 43:1239-1245.
60. Koivistoinen T., Virtanen M., Hutri-Kahonen N., et al. Arterial pulse wave velocity in relation to carotid intima-media thickness, brachial flow-mediated dilation and carotid artery distensibility: The cardiovascular risk in young finns study and the health 2000 survey. Atherosclerosis 2012, 220:387-393.
61. Blacher J., Asmar R., Djane S., London G.M., Safar M.E. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999, 33:1111-1117.
62. Blacher J., Guerin A.P., Pannier B., Marchais S.J., Safar M.E., London G.M. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999, 99:2434-2439.
63. Mitchell G.F., Hwang S.J., Vasan R.S., et al. Arterial stiffness and cardiovascular events: The framingham heart study. Circulation 2010, 121:505-511.
64. Ben-Shlomo Y., Spears M., Boustred C., et al. Aortic pulse wave velocity improves cardiovascular event prediction: An individual participant meta-analysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol 2014, 63:636-646.
65. Westerhof N., Westerhof B.E. A review of methods to determine the functional arterial parameters stiffness and resistance. J Hypertens 2013, 31:1769-1775.
66. Weber T., Auer J., O'Rourke M.F., et al. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 2004, 109:184-189.
67. Hayward C.S., Kraidly M., Webb C.M., Collins P. Assessment of endothelial function using peripheral waveform analysisA clinical application. J Am Coll Cardiol 2002, 40:521-528.
68. Wilkinson I.B., MacCallum H., Cockcroft J.R., Webb D.J. Inhibition of basal nitric oxide synthesis increases aortic augmentation index and pulse wave velocity in vivo. Br J Clin Pharmacol 2002, 53:189-192.
69. Schnabel R., Larson M.G., Dupuis J., et al. Relations of inflammatory biomarkers and common genetic variants with arterial stiffness and wave reflection. Hypertension 2008, 51:1651-1657.
70. O'Rourke M.F., Nichols W.W. Timing and amplitude of wave reflection. Hypertension 2007, 49:E3. [author reply E4].
71. van Sloten T.T., Schram M.T., van den Hurk K., et al. Local stiffness of the carotid and femoral artery is associated with incident cardiovascular events and all-cause mortality: The hoorn study. J Am Coll Cardiol 2014, 63:1739-1747.
72. McQuilkin G.L., Panthagani D., Metcalfe R.W., et al. Digital thermal monitoring (DTM) of vascular reactivity closely correlates with Doppler flow velocity. Conf Proc IEEE Eng Med Biol Soc 2009, 2009:1100-1103.
73. Ahmadi N., Usman N., Shim J., et al. Vascular dysfunction measured by fingertip thermal monitoring is associated with the extent of myocardial perfusion defect. J Nucl Cardiol 2009, 16:431-439.
74. Ahmadi N., McQuilkin G.L., Akhtar M.W., et al. Reproducibility and variability of digital thermal monitoring of vascular reactivity. Clin Physiol Funct Imaging 2011, 31:422-428.
75. Kloner R.A., Ganote C.E., Jennings R.B. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974, 54:1496-1508.
76. Kharbanda R.K., Peters M., Walton B., et al. Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo. Circulation 2001, 103:1624-1630.
77. Luca M.C., Liuni A., Muxel S., et al. Chronic pharmacological preconditioning against ischemia. Clin Hemorheol Microcirc 2011, 49:287-293.
78. Alhejily W., Aleksi A., Martin B.J., Anderson T.J. The effect of ischemia-reperfusion injury on measures of vascular function. Clin Hemorheol Microcirc 2014, 56:265-271.
79. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986, 74:1124-1136.
80. Jespersen L., Hvelplund A., Abildstrom S.Z., et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J 2012, 33:734-744.
81. Bugiardini R., Bairey Merz C.N. Angina with "normal" coronary arteries: A changing philosophy. JAMA 2005, 293:477-484.
82. Epstein S.E., Cannon R.O. Site of increased resistance to coronary flow in patients with angina pectoris and normal epicardial coronary arteries. J Am Coll Cardiol 1986, 8:459-461.
83. Agrawal S., Mehta P.K., Bairey Merz C.N. Cardiac syndrome X: Update 2014. Cardiol Clin 2014, 32:463-478.
84. Ong P., Athanasiadis A., Borgulya G., et al. Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries. Circulation 2014, 129:1723-1730.
85. Sedlak T.L., Johnson B.D., Pepine C.J., Reis S.E., Bairey Merz C.N. Brachial artery constriction during brachial artery reactivity testing predicts major adverse clinical outcomes in women with suspected myocardial ischemia: Results from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE) study. PLoS One 2013, 8:e74585.
86. D'Agostino R.B.S., Vasan R.S., Pencina M.J., et al. General cardiovascular risk profile for use in primary care: The framingham heart study. Circulation 2008, 117:743-753.
87. Budoff M.J., Young R., Lopez V.A., et al. Progression of coronary calcium and incident coronary heart disease events: MESA (multi-ethnic study of atherosclerosis). J Am Coll Cardiol 2013, 61:1231-1239.
88. Modena M.G., Bonetti L., Coppi F., Bursi F., Rossi R. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol 2002, 40:505-510.
89. Philpott A., Anderson T.J. Reactive hyperemia and cardiovascular risk. Arterioscler Thromb Vasc Biol 2007, 27:2065-2067.